Andrew Ahmann

11.9k total citations · 6 hit papers
69 papers, 6.5k citations indexed

About

Andrew Ahmann is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Andrew Ahmann has authored 69 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Surgery and 21 papers in Genetics. Recurrent topics in Andrew Ahmann's work include Diabetes Management and Research (43 papers), Diabetes Treatment and Management (28 papers) and Pancreatic function and diabetes (23 papers). Andrew Ahmann is often cited by papers focused on Diabetes Management and Research (43 papers), Diabetes Treatment and Management (28 papers) and Pancreatic function and diabetes (23 papers). Andrew Ahmann collaborates with scholars based in United States, United Kingdom and Canada. Andrew Ahmann's co-authors include Richard M. Bergenstal, Irl B. Hirsch, Roy W. Beck, Susan S. Braithwaite, Stephen Clement, Elizabeth Smith, Rebecca G. Schafer, Michelle Magee, Davida Kruger and John Welsh and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Andrew Ahmann

68 papers receiving 6.2k citations

Hit Papers

Management of Diabetes and Hyperglycemia in Hospitals 2004 2026 2011 2018 2004 2017 2010 2017 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Management of Diabetes and Hyperglycemia in Hospitals
    2004 898 citations Stephen Clement, Susan S. Braithwaite et al. Diabetes Care profile →
  2. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections
    2017 838 citations Roy W. Beck, Tonya D. Riddlesworth et al. profile →
  3. Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
    2010 651 citations Richard M. Bergenstal, Andrew Ahmann et al. profile →
  4. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections
    2017 449 citations Roy W. Beck, Tonya D. Riddlesworth et al. Annals of Internal Medicine profile →
  5. Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
    2017 438 citations Andrew Ahmann, Matthew Capehorn et al. Diabetes Care profile →
  6. Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia
    2013 428 citations Richard M. Bergenstal, Satish K. Garg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Ahmann United States 29 5.8k 2.9k 2.8k 786 340 69 6.5k
Olga Kordonouri Germany 46 4.5k 0.8× 3.2k 1.1× 3.9k 1.4× 586 0.7× 278 0.8× 222 6.5k
Ignacio Conget Spain 35 2.7k 0.5× 1.9k 0.6× 1.7k 0.6× 626 0.8× 401 1.2× 213 4.8k
Bruno Guerci France 39 3.6k 0.6× 1.6k 0.6× 1.1k 0.4× 1.3k 1.7× 515 1.5× 210 5.1k
Richard A. Oram United Kingdom 33 2.8k 0.5× 2.7k 0.9× 3.0k 1.1× 746 0.9× 286 0.8× 103 4.6k
Lois Jovanovič United States 38 2.8k 0.5× 2.0k 0.7× 1.1k 0.4× 464 0.6× 152 0.4× 118 5.0k
Thomas Danne Germany 36 3.6k 0.6× 2.5k 0.8× 2.2k 0.8× 285 0.4× 263 0.8× 192 4.8k
Emanuele Bosi Italy 49 4.4k 0.8× 3.5k 1.2× 3.8k 1.3× 1.5k 1.9× 802 2.4× 204 8.3k
R. Paul Wadwa United States 43 4.5k 0.8× 2.7k 0.9× 2.5k 0.9× 229 0.3× 312 0.9× 143 5.9k
Stephen D. Luzio United Kingdom 33 2.5k 0.4× 1.2k 0.4× 752 0.3× 837 1.1× 551 1.6× 175 4.6k
Parth Narendran United Kingdom 33 2.2k 0.4× 1.1k 0.4× 1.4k 0.5× 303 0.4× 449 1.3× 145 3.4k

Countries citing papers authored by Andrew Ahmann

Since Specialization
Citations

This map shows the geographic impact of Andrew Ahmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Ahmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Ahmann more than expected).

Fields of papers citing papers by Andrew Ahmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Ahmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Ahmann. The network helps show where Andrew Ahmann may publish in the future.

Co-authorship network of co-authors of Andrew Ahmann

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Ahmann. A scholar is included among the top collaborators of Andrew Ahmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Ahmann. Andrew Ahmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Barzilay, Joshua I., Alokananda Ghosh, Rodica Pop‐Busui, et al.. (2021). The cross-sectional association of cognition with diabetic peripheral and autonomic neuropathy—The GRADE study. Journal of Diabetes and its Complications. 35(12). 108047–108047. 6 indexed citations
3.
Fisher, Lawrence, Danielle Hessler, William H. Polonsky, et al.. (2018). T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes. Diabetes Care. 41(9). 1862–1869. 71 indexed citations
4.
Beck, Roy W., Tonya D. Riddlesworth, Katrina J. Ruedy, et al.. (2017). Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections. Annals of Internal Medicine. 167(6). 365–374. 449 indexed citations breakdown →
5.
Aleppo, Grazia, Lori M. Laffel, Andrew Ahmann, et al.. (2017). A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes. Journal of the Endocrine Society. 1(12). 1445–1460. 85 indexed citations
6.
Peters, Anne L., Andrew Ahmann, Tadej Battelino, et al.. (2016). Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 101(11). 3922–3937. 163 indexed citations
7.
Weiss, Ram, Satish K. Garg, Bruce W. Bode, et al.. (2015). Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study. Diabetes Technology & Therapeutics. 17(8). 542–547. 43 indexed citations
8.
Ahmann, Andrew. (2015). Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin. Drugs in Context. 4(4). 1–7. 5 indexed citations
9.
Bailey, Timothy S., Andrew Ahmann, Ronald Brazg, et al.. (2014). Accuracy and Acceptability of the 6-Day Enlite Continuous Subcutaneous Glucose Sensor. Diabetes Technology & Therapeutics. 16(5). 277–283. 71 indexed citations
10.
Ahmann, Andrew, et al.. (2013). Comparing Patient Preferences and Healthcare Provider Recommendations with the Pen Versus Vial-and-Syringe Insulin Delivery in Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics. 16(2). 76–83. 29 indexed citations
11.
Long, S. Alice, Mary Rieck, Srinath Sanda, et al.. (2012). Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function. Diabetes. 61(9). 2340–2348. 255 indexed citations
12.
Ahmann, Andrew & Greg Maynard. (2008). Designing and implementing insulin infusion protocols and order sets. Journal of Hospital Medicine. 3(S5). 42–54. 18 indexed citations
13.
Clement, Stephen, Susan S. Braithwaite, Michelle Magee, et al.. (2004). Management of Diabetes and Hyperglycemia in Hospitals. Diabetes Care. 27(2). 553–591. 898 indexed citations breakdown →
14.
Ahmann, Andrew. (2004). Inpatient management of hospitalized patients with type 2 diabetes. Current Diabetes Reports. 4(5). 346–351. 7 indexed citations
15.
Ahmann, Andrew. (2004). Reduction of Hospital Costs and Length of Stay by Good Control of Blood Glucose Levels. Endocrine Practice. 10. 53–56. 34 indexed citations
16.
Ahmann, Andrew & Matthew C. Riddle. (2002). Current oral agents for type 2 diabetes. Postgraduate Medicine. 111(5). 32–46. 14 indexed citations
17.
Kaulfersch, W, et al.. (1989). MOLEKULARGENETISCHER NACHWEIS EINER POLYKLONALEN IMMUNANTWORT BEI AUTOIMMUNTHYREOIDITIS UND ENTZUNDLICHEN DARMERKRANKUNGEN. Monatsschrift Kinderheilkunde. 137(9). 610–615. 2 indexed citations
18.
Burman, Kenneth D., et al.. (1989). Effects of Epidermal Growth Factor on Thyroglobulin and Adenosine 3’,5’-Monophosphate Production by Cultured Human Thyrocytes. The Journal of Clinical Endocrinology & Metabolism. 69(4). 771–775. 12 indexed citations
19.
Kaulfersch, W, et al.. (1988). Immunoglobulin and T Cell Antigen Receptor Gene Arrangements Indicate That the Immune Response in Autoimmune Thyroid Disease Is Polyclonal*. The Journal of Clinical Endocrinology & Metabolism. 66(5). 958–963. 16 indexed citations
20.
Ahmann, Andrew, James R. Baker, Anthony P. Weetman, et al.. (1987). Antibodies to Porcine Eye Muscle in Patients with Graves’ Ophthalmopathy: Identification of Serum Immunoglobulins Directed Against Unique Determinants by Immunoblotting and Enzyme-Linked Immunosorbent Assay*. The Journal of Clinical Endocrinology & Metabolism. 64(3). 454–460. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olga Kordonouri Breakdown of academic impact, for papers by Ignacio Conget Breakdown of academic impact, for papers by Bruno Guerci Breakdown of academic impact, for papers by Richard A. Oram Breakdown of academic impact, for papers by Lois Jovanovič Breakdown of academic impact, for papers by Thomas Danne Breakdown of academic impact, for papers by Emanuele Bosi Breakdown of academic impact, for papers by R. Paul Wadwa Breakdown of academic impact, for papers by Stephen D. Luzio Breakdown of academic impact, for papers by Parth Narendran
Rankless by CCL
2026